Functional characterisation of the osteoarthritis susceptibility locus at chromosome 6q14.1 marked by the polymorphism rs9350591

BMC Medical Genetics

Volumn 16, Issue 1, 2015, Pages

  Johnson, Katherine ^a   Reynard, Louise N ^a   Loughlin, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; ARTICULAR CARTILAGE; CELL DIFFERENTIATION; CHONDROGENESIS; CHROMOSOME 6Q; COL12A1 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIP OSTEOARTHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MESENCHYMAL STEM CELL; MYO6 GENE; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PYROSEQUENCING; QUANTITATIVE TRAIT LOCUS; SENP6 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TMEM30A GENE; CAUCASIAN; CHROMOSOME 6; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ODDS RATIO;

BASE SEQUENCE; CHONDROGENESIS; CHROMOSOMES, HUMAN, PAIR 6; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MOLECULAR SEQUENCE DATA; ODDS RATIO; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84940837087     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-015-0215-9     Document Type: Article

References (19)

1. Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005;365(9463):965-73. doi: 10.1016/S0140-6736(05)71086-2 .
2. Loughlin J. Genetics of osteoarthritis. Curr Opin Rheumatol. 2011;23(5):479-83. doi: 10.1097/BOR.0b013e3283493ff0 .
3. Reynard LN, Loughlin J. The genetics and functional analysis of primary osteoarthritis susceptibility. Expert Rev Mol Med. 2013;15, e2. doi: 10.1017/erm.2013.4 .
4. Zeggini E, Panoutsopoulou K, Southam L, Rayner NW, Day-Williams AG, Lopes MC, et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet. 2012;380(9844):815-23. doi: 10.1016/S0140-6736(12)60681-3 .
5. Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Gomez-Marin C, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507(7492):371-5. doi: 10.1038/nature13138 .
6. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M. Mapping complex disease traits with global gene expression. Nat Rev Genet. 2009;10(3):184-94. doi: 10.1038/nrg2537 .
7. Egli RJ, Southam L, Wilkins JM, Lorenzen I, Pombo-Suarez M, Gonzalez A, et al. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum. 2009;60(7):2055-64. doi: 10.1002/art.24616 .
8. Gee F, Clubbs CF, Raine EV, Reynard LN, Loughlin J. Allelic expression analysis of the osteoarthritis susceptibility locus that maps to chromosome 3p21 reveals cis-acting eQTLs at GNL3 and SPCS1. BMC Med Genet. 2014;15:53. doi: 10.1186/1471-2350-15-53 .
9. Bos SD, Bovee JV, Duijnisveld BJ, Raine EV, van Dalen WJ, Ramos YF, et al. Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis. 2012;71(7):1254-8. doi: 10.1136/annrheumdis-2011-200981 .
10. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24(24):2938-9. doi: 10.1093/bioinformatics/btn564 .
11. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790-7. doi: 10.1101/gr.137323.112 .
12. Ratnayake M, Reynard LN, Raine EV, Santibanez-Koref M, Loughlin J. Allelic expression analysis of the osteoarthritis susceptibility locus that maps to MICAL3. BMC Med Genet. 2012;13:12. doi: 10.1186/1471-2350-13-12 .
13. Tew SR, Murdoch AD, Rauchenberg RP, Hardingham TE. Cellular methods in cartilage research: primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods. 2008;45(1):2-9. doi: 10.1016/j.ymeth.2008.01.006 .
14. Reynard LN, Loughlin J. Insights from human genetic studies into the pathways involved in osteoarthritis. Nat Rev Rheumatol. 2013;9(10):573-83. doi: 10.1038/nrrheum.2013.121 .
15. Raine EV, Wreglesworth N, Dodd AW, Reynard LN, Loughlin J. Gene expression analysis reveals HBP1 as a key target for the osteoarthritis susceptibility locus that maps to chromosome 7q22. Ann Rheum Dis. 2012;71(12):2020-7. doi: 10.1136/annrheumdis-2012-201304 .
16. Aschenbrenner L, Naccache SN, Hasson T. Uncoated endocytic vesicles require the unconventional myosin, Myo6, for rapid transport through actin barriers. Mol Biol Cell. 2004;15(5):2253-63. doi: 10.1091/mbc.E04-01-0002 .
17. Sanggaard KM, Kjaer KW, Eiberg H, Nurnberg G, Nurnberg P, Hoffman K, et al. A novel nonsense mutation in MYO6 is associated with progressive nonsyndromic hearing loss in a Danish DFNA22 family. Am J Med Genet A. 2008;146A(8):1017-25. doi: 10.1002/ajmg.a.32174 .
18. Lima CD, Reverter D. Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J Biol Chem. 2008;283(46):32045-55. doi: 10.1074/jbc.M805655200 .
19. Yan D, Davis FJ, Sharrocks AD, Im HJ. Emerging roles of SUMO modification in arthritis. Gene. 2010;466(1-2):1-15. doi: 10.1016/j.gene.2010.07.003 .